| 摘要 |
The combined administration of: (a) one or more macrolide anthelmintic agents selected from the group consisting of B-41 series antibiotics, C-076 series antibiotics and 22,23-dihydro C-076 derivatives; and (b) one or more anthelmintic agents selected from the group consisting of benzimidazole, salicylamide and isoquinoline compounds, has been bound to exhibit enhanced anthelmintic activity as compared with the additive use of the individual compounds.
|
